WFDC2 is upregulated in lung cancer [56–58] and has thus recognized the clinical application of WFDC2 as a serum tumor marker in the early diagnosis and efficacy monitoring of lung cancer [59]. This evidence concerns the gene WFDC2 and lung cancer.